New center dedicated to kidney disease

Kidney disease is the eighth most common cause of death in the United States and affects more than 20 million people, yet many people don’t know they have kidney disease because it often develops very slowly and with minimal symptoms. For this reason, kidney disease is often referred to as a silent killer.

Normalizing calcium flux to treat atrial fibrillation

A particular anti-arrhythmia drug provides a targeted treatment for certain forms of atrial fibrillation.

Nighttime dialysis treatments available

Vanderbilt University Medical Center, committed to providing multiple options to patients who have kidney disease, recently began offering nocturnal in-center hemodialysis, which allows patients to receive treatment at night while they sleep.

Cutting-edge research to be showcased in May

Schaffner honored by pharmacy association

William Schaffner, M.D., professor of Preventive Medicine at Vanderbilt University Medical Center, received the Immunization Champion Award — Friend of Pharmacy from the American Pharmacists Association (APA) at the group’s annual meeting recently in Orlando, Fla.

Physical signs of depression common among ICU survivors

Depression affects more than one out of three survivors of critical illness, according to a Vanderbilt study released in The Lancet Respiratory Medicine, and the majority of patients experience their symptoms physically rather than mentally.